Next-Generation Diabetic Foot Care Platform

Publication ID: 24-11857303_0005_PTD
Published: November 07, 2025
Category:Future Evolutions & Paradigm Shifts

Legal Citation

pr1or.art Inc., “Next-Generation Diabetic Foot Care Platform,” Published Technical Disclosure No. 24-11857303_0005_PTD, Published November 07, 2025, available at https://archive.pr1or.art/24-11857303_0005_PTD
This technical disclosure describes improvements that would be readily apparent to a Person Having Ordinary Skill In The Art (PHOSITA) when considered in combination with the foundational architecture disclosed in U.S. Patent No. 11,857,303.

Summary of the Inventive Concept

A wearable, machine learning-driven system for predicting and preventing diabetic foot ulcers, leveraging advanced PPG signal analysis and real-time feedback to patients and healthcare providers.

Background and Problem Solved

The original patent's apparatus and method for measuring blood flow in the foot, while innovative, have limitations in detecting early signs of diabetic foot complications. The new inventive concept addresses these limitations by introducing a paradigm shift in diabetic foot care, integrating machine learning, real-time monitoring, and personalized treatment plans to prevent ulceration and improve patient outcomes.

Detailed Description of the Inventive Concept

The next-generation diabetic foot care platform comprises a wearable device with embedded PPG sensors, a machine learning module, and a notification system. The device analyzes PPG signals to identify patterns indicative of increased risk of ulceration and alerts patients or healthcare providers in real-time. The platform also integrates electronic health records, medical history, and lifestyle data to generate customized treatment plans. Additionally, the system includes a telemedicine module for remote consultations, enabling timely interventions and improved patient care.

Novelty and Inventive Step

The new claims introduce a novel combination of machine learning, real-time monitoring, and personalized treatment plans, which constitutes a significant departure from the original patent's apparatus and method. The inventive step lies in the integration of these components to create a proactive, patient-centric platform for diabetic foot care.

Alternative Embodiments and Variations

Alternative embodiments of the inventive concept may include handheld devices, smart insoles, or cloud-based analytics platforms. Variations could incorporate additional sensors, such as temperature or pressure sensors, to provide a more comprehensive picture of foot health.

Potential Commercial Applications and Market

The next-generation diabetic foot care platform has significant commercial potential in the healthcare industry, particularly in the fields of diabetes management, wound care, and telemedicine. The platform's ability to prevent ulceration, reduce healthcare costs, and improve patient outcomes positions it for widespread adoption in hospitals, clinics, and patient homes.

Original Patent Information

Patent NumberUS 11,857,303
TitleApparatus and method of measuring blood flow in the foot
Assignee(s)Podimetrics, Inc.